James Tanner McMahon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ciliary Motility Disorders | 1 | 2011 | 51 | 0.360 |
Why?
|
| Glioma | 2 | 2022 | 3418 | 0.350 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2011 | 105 | 0.350 |
Why?
|
| Hair Diseases | 1 | 2007 | 72 | 0.270 |
Why?
|
| Hair | 1 | 2007 | 497 | 0.220 |
Why?
|
| Antigen-Antibody Complex | 1 | 2002 | 513 | 0.180 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2019 | 66 | 0.170 |
Why?
|
| Athletic Performance | 1 | 2020 | 105 | 0.170 |
Why?
|
| Yttrium Radioisotopes | 1 | 2019 | 107 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2646 | 0.130 |
Why?
|
| Running | 1 | 2020 | 483 | 0.130 |
Why?
|
| Cilia | 2 | 2011 | 493 | 0.130 |
Why?
|
| Complement C4b | 2 | 2014 | 132 | 0.130 |
Why?
|
| Polypharmacy | 1 | 2018 | 305 | 0.120 |
Why?
|
| Football | 1 | 2020 | 502 | 0.120 |
Why?
|
| Meningioma | 1 | 2023 | 1217 | 0.120 |
Why?
|
| Meningeal Neoplasms | 1 | 2023 | 1247 | 0.110 |
Why?
|
| Drug Interactions | 1 | 2018 | 1414 | 0.110 |
Why?
|
| Cryptococcus | 1 | 2013 | 28 | 0.110 |
Why?
|
| Histones | 1 | 2023 | 2577 | 0.110 |
Why?
|
| Sweet Syndrome | 1 | 2013 | 58 | 0.100 |
Why?
|
| Cryptococcosis | 1 | 2013 | 104 | 0.100 |
Why?
|
| Complement Activation | 1 | 2014 | 446 | 0.100 |
Why?
|
| Riboflavin | 1 | 2012 | 105 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2002 | 2083 | 0.100 |
Why?
|
| Dermatitis | 1 | 2013 | 200 | 0.090 |
Why?
|
| Rescue Work | 1 | 2011 | 56 | 0.090 |
Why?
|
| Food Analysis | 2 | 2008 | 103 | 0.090 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2010 | 42 | 0.090 |
Why?
|
| Orbital Pseudotumor | 1 | 2010 | 42 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 1407 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3615 | 0.080 |
Why?
|
| Cross-Linking Reagents | 1 | 2012 | 685 | 0.080 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 229 | 0.080 |
Why?
|
| New York City | 1 | 2011 | 725 | 0.080 |
Why?
|
| Amantadine | 1 | 2008 | 57 | 0.080 |
Why?
|
| Dyneins | 1 | 2008 | 124 | 0.080 |
Why?
|
| Myocytes, Cardiac | 2 | 2010 | 1655 | 0.080 |
Why?
|
| Kidney | 2 | 2005 | 7016 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 1780 | 0.080 |
Why?
|
| Photosensitizing Agents | 1 | 2012 | 618 | 0.070 |
Why?
|
| Corneal Edema | 1 | 2008 | 47 | 0.070 |
Why?
|
| Silicone Gels | 1 | 2007 | 39 | 0.070 |
Why?
|
| Titanium | 1 | 2010 | 484 | 0.070 |
Why?
|
| Meat Products | 1 | 2007 | 96 | 0.070 |
Why?
|
| Dopamine Agents | 1 | 2008 | 189 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2010 | 591 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 1076 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2292 | 0.070 |
Why?
|
| Foreign-Body Reaction | 1 | 2007 | 157 | 0.070 |
Why?
|
| Biopsy | 6 | 2014 | 6768 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2018 | 2155 | 0.070 |
Why?
|
| Lymphatic Diseases | 1 | 2007 | 319 | 0.060 |
Why?
|
| Uveal Neoplasms | 1 | 2009 | 341 | 0.060 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2009 | 353 | 0.060 |
Why?
|
| Collagen | 2 | 2012 | 2635 | 0.060 |
Why?
|
| Meat | 1 | 2008 | 584 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2014 | 1296 | 0.060 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2008 | 370 | 0.060 |
Why?
|
| Bronchi | 1 | 2008 | 848 | 0.060 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2010 | 615 | 0.060 |
Why?
|
| Cornea | 1 | 2012 | 1326 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4313 | 0.060 |
Why?
|
| Antimalarials | 1 | 2010 | 905 | 0.060 |
Why?
|
| Breast Implants | 1 | 2007 | 409 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 2009 | 523 | 0.050 |
Why?
|
| Food | 1 | 2008 | 771 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2014 | 5098 | 0.050 |
Why?
|
| Hematoxylin | 1 | 2002 | 60 | 0.050 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2002 | 69 | 0.050 |
Why?
|
| Microtubules | 1 | 2008 | 1072 | 0.050 |
Why?
|
| Microscopy | 1 | 2007 | 884 | 0.050 |
Why?
|
| Molluscum Contagiosum | 1 | 2002 | 15 | 0.050 |
Why?
|
| Autophagy | 1 | 2010 | 1322 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2325 | 0.050 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2002 | 85 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2002 | 241 | 0.050 |
Why?
|
| Lung | 1 | 2019 | 9985 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2002 | 358 | 0.050 |
Why?
|
| Inclusion Bodies | 1 | 2002 | 281 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 8981 | 0.040 |
Why?
|
| Neutrophils | 1 | 2013 | 3765 | 0.040 |
Why?
|
| Acceleration | 1 | 2020 | 189 | 0.040 |
Why?
|
| Nevus, Pigmented | 1 | 2002 | 221 | 0.040 |
Why?
|
| Humans | 22 | 2023 | 758406 | 0.040 |
Why?
|
| Histocompatibility Testing | 2 | 2014 | 717 | 0.040 |
Why?
|
| Geographic Information Systems | 1 | 2020 | 281 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2002 | 1083 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7502 | 0.040 |
Why?
|
| Heart Conduction System | 1 | 2003 | 1011 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2010 | 3806 | 0.040 |
Why?
|
| Pulmonary Veins | 1 | 2003 | 745 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 29915 | 0.040 |
Why?
|
| Craniotomy | 1 | 2021 | 741 | 0.040 |
Why?
|
| Myocardium | 1 | 2010 | 4690 | 0.040 |
Why?
|
| Eosinophils | 1 | 2002 | 946 | 0.040 |
Why?
|
| Air Pollutants | 1 | 2011 | 2842 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 12951 | 0.030 |
Why?
|
| Adult | 8 | 2022 | 219935 | 0.030 |
Why?
|
| Biological Transport | 1 | 2019 | 2084 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2023 | 42062 | 0.030 |
Why?
|
| Australia | 1 | 2018 | 1276 | 0.030 |
Why?
|
| Female | 12 | 2023 | 390323 | 0.030 |
Why?
|
| Prednisone | 2 | 2010 | 1565 | 0.030 |
Why?
|
| Ohio | 1 | 2014 | 321 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2002 | 2907 | 0.030 |
Why?
|
| Histocompatibility | 1 | 2014 | 316 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2005 | 4426 | 0.030 |
Why?
|
| Cattle | 2 | 2008 | 3845 | 0.030 |
Why?
|
| Microscopy, Polarization | 1 | 2012 | 89 | 0.030 |
Why?
|
| Corneal Topography | 1 | 2012 | 68 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 2002 | 1233 | 0.020 |
Why?
|
| Collagenases | 1 | 2012 | 221 | 0.020 |
Why?
|
| Water | 2 | 2008 | 1402 | 0.020 |
Why?
|
| Skin Ulcer | 1 | 2013 | 129 | 0.020 |
Why?
|
| HIV Infections | 1 | 2018 | 17275 | 0.020 |
Why?
|
| Middle Aged | 9 | 2018 | 219568 | 0.020 |
Why?
|
| Aged | 6 | 2019 | 168218 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2012 | 527 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2005 | 2557 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2005 | 4217 | 0.020 |
Why?
|
| Desmin | 1 | 2010 | 99 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5864 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2470 | 0.020 |
Why?
|
| Myofibrils | 1 | 2010 | 141 | 0.020 |
Why?
|
| Exophthalmos | 1 | 2010 | 97 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64378 | 0.020 |
Why?
|
| Sarcocystis | 1 | 2008 | 5 | 0.020 |
Why?
|
| Kartagener Syndrome | 1 | 2008 | 33 | 0.020 |
Why?
|
| Visual Acuity | 2 | 2009 | 2642 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 437 | 0.020 |
Why?
|
| Turkeys | 1 | 2007 | 45 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2008 | 194 | 0.020 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2007 | 33 | 0.020 |
Why?
|
| Manometry | 1 | 2010 | 453 | 0.020 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2008 | 144 | 0.020 |
Why?
|
| Male | 10 | 2023 | 358747 | 0.020 |
Why?
|
| Consumer Product Safety | 1 | 2007 | 122 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2021 | 80168 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2008 | 416 | 0.020 |
Why?
|
| Tubulin | 1 | 2010 | 692 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2012 | 1288 | 0.020 |
Why?
|
| Heart Failure | 1 | 2010 | 11593 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 2008 | 412 | 0.020 |
Why?
|
| Chickens | 1 | 2007 | 860 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11070 | 0.020 |
Why?
|
| Clavicle | 1 | 2007 | 224 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 1630 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 1668 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2003 | 5103 | 0.010 |
Why?
|
| Benzamides | 1 | 2010 | 1368 | 0.010 |
Why?
|
| Cartilage | 1 | 2008 | 806 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 2005 | 384 | 0.010 |
Why?
|
| Azathioprine | 1 | 2005 | 356 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2021 | 15637 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2010 | 1471 | 0.010 |
Why?
|
| Mycophenolic Acid | 1 | 2005 | 343 | 0.010 |
Why?
|
| Sinoatrial Node | 1 | 2003 | 99 | 0.010 |
Why?
|
| Molluscum contagiosum virus | 1 | 2002 | 4 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29557 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2002 | 5797 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2005 | 859 | 0.010 |
Why?
|
| Infertility | 1 | 2008 | 655 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 1627 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2005 | 664 | 0.010 |
Why?
|
| Living Donors | 1 | 2005 | 638 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 1400 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2008 | 1005 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5781 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 6293 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2013 | 2159 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2005 | 1368 | 0.010 |
Why?
|
| Piperazines | 1 | 2010 | 2511 | 0.010 |
Why?
|
| Cadaver | 1 | 2003 | 1345 | 0.010 |
Why?
|
| Skin | 1 | 2013 | 4464 | 0.010 |
Why?
|
| Scalp | 1 | 2002 | 389 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2010 | 3006 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2008 | 2560 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2005 | 2610 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 58683 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 5892 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15225 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 2420 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9518 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2005 | 2154 | 0.010 |
Why?
|
| Contrast Media | 1 | 2010 | 5298 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 4809 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 25956 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 5952 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5249 | 0.010 |
Why?
|
| Graft Survival | 1 | 2005 | 3794 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4567 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22029 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 58808 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9404 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9267 | 0.010 |
Why?
|
| Adolescent | 3 | 2008 | 87892 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 4902 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2008 | 3204 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13468 | 0.010 |
Why?
|
| Animals | 3 | 2010 | 167768 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2008 | 5079 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18119 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39059 | 0.000 |
Why?
|
| Phenotype | 1 | 2005 | 16534 | 0.000 |
Why?
|
| Infant | 1 | 2008 | 36055 | 0.000 |
Why?
|
| Time Factors | 1 | 2005 | 39872 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 81101 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 36284 | 0.000 |
Why?
|
| Child | 1 | 2008 | 79818 | 0.000 |
Why?
|